UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Cal-Maine
CALM
$3.99B
| $1.76M | ﹤0.01% |
35,556
+4,493
| +14% | +$228K |
|
1677
First Commonwealth Financial
FCF
$2.17B
| $1.76M | ﹤0.01% |
130,865
-437
| -0.3% | -$6.05K |
|
|
GCP
1678
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.75M | ﹤0.01% |
56,048
+6,159
| +12% | +$192K |
|
|
CCXI
1679
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.73M | ﹤0.01% |
69,953
+971
| +1% | +$21.4K |
|
1680
Iovance Biotherapeutics
IOVA
$2.87B
| $1.73M | ﹤0.01% |
156,807
-60,728
| -28% | -$796K |
|
1681
Kforce
KFRC
$1.06B
| $1.72M | ﹤0.01% |
28,112
+174
| +0.6% | +$11.9K |
|
1682
Nabors Industries
NBR
$1.21B
| $1.72M | ﹤0.01% |
12,864
-1,001
| -7% | -$157K |
|
1683
Granite Construction
GVA
$5.62B
| $1.72M | ﹤0.01% |
59,042
-3,093
| -5% | -$96.1K |
|
1684
Customers Bancorp
CUBI
$2.77B
| $1.72M | ﹤0.01% |
50,643
-784
| -2% | -$31.9K |
|
1685
StoneX
SNEX
$7.94B
| $1.72M | ﹤0.01% |
111,243
| – | – |
|
|
HTLF
1686
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.71M | ﹤0.01% |
41,265
-1,180
| -3% | -$51.9K |
|
|
PING
1687
DELISTED
Ping Identity Holding Corp.
PING
| $1.71M | ﹤0.01% |
94,447
-1,399
| -1% | -$31.1K |
|
1688
GrafTech
EAF
$212M
| $1.71M | ﹤0.01% |
24,185
+721
| +3% | +$62.8K |
|
|
BBT
1689
Beacon Financial Corp
BBT
$2.66B
| $1.7M | ﹤0.01% |
68,746
-5,629
| -8% | -$146K |
|
1690
Telephone and Data Systems
TDS
$3.75B
| $1.7M | ﹤0.01% |
107,386
+4,985
| +5% | +$89K |
|
1691
GlobalFoundries
GFS
$29.6B
| $1.69M | ﹤0.01% |
+41,981
| New | +$2.22M |
|
|
SGFY
1692
DELISTED
Signify Health, Inc.
SGFY
| $1.69M | ﹤0.01% |
122,319
+50,041
| +69% | +$705K |
|
1693
Strategy Inc
MSTR
$38.4B
| $1.69M | ﹤0.01% |
102,710
+2,780
| +3% | +$80.4K |
|
1694
Sally Beauty Holdings
SBH
$1.58B
| $1.69M | ﹤0.01% |
141,377
+2,729
| +2% | +$39.6K |
|
|
SAGE
1695
DELISTED
Sage Therapeutics
SAGE
| $1.68M | ﹤0.01% |
52,067
-22,054
| -30% | -$739K |
|
1696
Healthcare Services Group
HCSG
$1.53B
| $1.68M | ﹤0.01% |
96,389
+4,896
| +5% | +$84.4K |
|
|
QVCGA
1697
DELISTED
QVC Group Inc Series A
QVCGA
| $1.67M | ﹤0.01% |
11,669
-4,972
| -30% | -$965K |
|
1698
Cheesecake Factory
CAKE
$5.33B
| $1.67M | ﹤0.01% |
63,301
-45
| -0.1% | -$1.5K |
|
|
SASR
1699
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.67M | ﹤0.01% |
42,804
-10,130
| -19% | -$414K |
|
1700
Southside Bancshares
SBSI
$967M
| $1.67M | ﹤0.01% |
44,656
+209
| +0.5% | +$8.14K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.